glp-1 compound podcast Studio Maybe i’m not against compounding
Description
in its 12th acquisition of '26, Lilly enters the psychedelics aisle w/$2.8B upfront move for AtaiBeckley GLP-1 giant, once known for its depression med Prozac, gets 3 clinical-stage brain health drug candidates follows J&J, AbbVie, Otsuka in psychedelics
Thinking about a GLP-1 medication
The pricing adjustment, effective immediately, represents an early organizational response to []
Thats not a typo
Weight loss plateaus can be frustrating, especially when youve been seeing results with GLP-1 medications
Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care
